Agajanian Institute of Oncology and Hematology
Whittier, California, United States
Internist in Whittier, California
8135 Painter Ave Ste 103, Whittier, CA 90602
About Agajanian Institute of Oncology and Hematology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Agajanian Institute of Oncology and Hematology
During the past decade, Agajanian Institute of Oncology and Hematology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
1996-04-01
Unknown status
1,000
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer
1993-03-01
Unknown status
280
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer
1994-12-01
2002-01-01
Completed
180
Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment
1999-12-01
2002-01-01
Completed
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1998-10-01
Active, not recruiting
1,649
Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma
2000-06-01
Unknown status
1,258
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
2000-09-01
Unknown status
Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct
1999-01-01
Unknown status
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Agajanian Institute of Oncology and Hematology
According to Clinical.Site data, the most researched conditions in "Agajanian Institute of Oncology and Hematology" are
"Kidney Neoplasms" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Agajanian Institute of Oncology and Hematology" in a lesser frequency.
Clinical Trials Intervention Types at Agajanian Institute of Oncology and Hematology
Most popular intervention types in "Agajanian Institute of Oncology and Hematology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "ABR-215050, tasquinimod" (1 trials), "Axitinib (AG-013736)" (1 trials), "Placebo" (1 trials) and "Sorafenib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Agajanian Institute of Oncology and Hematology
The vast majority of trials in "Agajanian Institute of Oncology and Hematology" are
1 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Agajanian Institute of Oncology and Hematology
Currently, there are NaN active trials in "Agajanian Institute of Oncology and Hematology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Agajanian Institute of Oncology and Hematology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Agajanian Institute of Oncology and Hematology, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".